美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
SUBOXONE	020733	001	NDA	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	TABLET;SUBLINGUAL	EQ 2MG BASE;EQ 0.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2002/10/08	2002/10/08	INDIVIOR	Discontinued
SUBOXONE	020733	002	NDA	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	TABLET;SUBLINGUAL	EQ 8MG BASE;EQ 2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2002/10/08	2002/10/08	INDIVIOR	Discontinued
SUBOXONE	022410	001	NDA	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	FILM;BUCCAL, SUBLINGUAL	EQ 2MG BASE;EQ 0.5MG BASE	Yes	No	2010/08/30	2010/08/30	INDIVIOR	Prescription
SUBOXONE	022410	002	NDA	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	FILM;BUCCAL, SUBLINGUAL	EQ 8MG BASE;EQ 2MG BASE	Yes	No	2010/08/30	2010/08/30	INDIVIOR	Prescription
SUBOXONE	022410	003	NDA	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	FILM;BUCCAL, SUBLINGUAL	EQ 4MG BASE;EQ 1MG BASE	Yes	No	2010/08/30	2012/08/10	INDIVIOR	Prescription
SUBOXONE	022410	004	NDA	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	FILM;BUCCAL, SUBLINGUAL	EQ 12MG BASE;EQ 3MG BASE	Yes	Yes	2010/08/30	2012/08/10	INDIVIOR	Prescription